Anthony Barboza/Getty Over the course of his 50-plus-year career, Donaldson was revered for his thoughtful, bluesy approach to the alto saxophone. His unique style earned him several hits ...

Lou Donaldson, acclaimed jazz alto saxophonist, died over the weekend according to a statement from his family. He was 98. A pop-up statement on Donaldson's website reads, "The Family of Sweet ...

"Thankfully no one was injured," a spokesperson for Flecha Cantina tells PEOPLE Mark Gray is a journalist of over two decades. He has written about entertainment, sports and crime since 2001 ...

With a pair of touchdown catches against the Tampa Bay Buccaneers on Monday night, tight end Mark Andrews took sole possession of the Ravens’ all-time record in career receiving touchdowns with 43.

Steve Sax said the Dodgers really shine in their offense and said this team has everything when it comes to star quality. What Trump's win means for Ukraine, Middle East and China I've spent 25 ...

After Hamill left the stream, YouTuber and author Hank Green and billionaire Mark Cuban joined the conversation to discuss their support for Harris, while also joking about the youth-facing ...

1:55 ‘We need solutions’: Mark Carney hopes to reverse Liberals’ fortunes Mark Carney said he is thinking about running for elected office in Canada, but remained guarded about when or where ...

A lot of billionaires seem hellbent on reelecting Donald Trump. In return, the Republican candidate has promised that their support will pay dividends. Given all this mutual affinity, it certainly ...

The billionaire businessman Mark Cuban on Monday said the presidential campaign had become a battle between Vice President Kamala Harris and Tesla CEO Elon Musk rather than Donald Trump.

Alto Neuroscience hit a bum note in an early test of its precision neuropsychiatry model. A phase 2b trial of Alto’s lead drug candidate in depression missed its primary and key secondary ...

Alto Neuroscience (NYSE:ANRO) shares nosedived 66% Wednesday morning, the first trading session, after the company announced its psychiatric drug ALTO-100 had failed a key clinical study. After ...